|Free Dividend Report|
|Stock Splits Calendar|
|RCKT Stock Split History|
|Preferred Stock Newsletter|
|RCKT Options Chain|
|Stock Message Boards|
Rocket Pharmaceuticals (RCKT) has 1 split in our RCKT split history database. The split for RCKT took place on January 05, 2018. This was a 1 for 4 reverse split, meaning for each 4 shares of RCKT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.
When a company such as Rocket Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the RCKT split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Rocket Pharmaceuticals shares, starting with a $10,000 purchase of RCKT, presented on a split-history-adjusted basis factoring in the complete RCKT split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-2.92%|
|About Rocket Pharmaceuticals|
|Rocket Pharmaceuticals is a biotechnology company focused on the development of gene therapies for rare and devastating diseases. Co. has various clinical-stage ex vivo lentiviral vector programs. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. In the U.S., Co. has a clinical stage in vivo adeno-associated virus program for Danon disease. According to our RCKT split history records, Rocket Pharmaceuticals has had 1 split.|
|RCKT Split History Table|
|01/05/2018||1 for 4|
|Healthcare Stock Splits|
|RCKT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: RCKT shares outstanding history
RCKT Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.1%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.1%.